6 hospitalized, one brain-dead, in French clinical drug trial

The tests were conducted in a licenced private facility.
By Ed Adamczyk Contact the Author   |   Jan. 15, 2016 at 10:30 AM

RENNES , France, Jan. 15 (UPI) -- Six patients participating in a clinical drug trial in France were hospitalized, one with brain damage, the French health minister said Friday.

The drug was in a Phase 1 clinical trial and being tested on healthy volunteers in a licensed private facility specializing in clinical trials, said Marisol Touraine, minister for social affairs, health and women's rights, in a statement.

No information was released about the drug other than it was administered orally.

The sickened were transported to a hospital in the northwestern French town of Rennes. One victim was declared brain-dead and in intensive care, the statement said.

Deaths or other adverse reactions in Phase 1 trials, which focus on safety and side effects and not on a medication's usefulness, are rare.

Touraine said she would travel to Rennes and said France's regulatory agency for medical devices announced it will inspect the site of the trials.

Follow us on Facebook, Twitter, and Instagram for more news from UPI.com
Related UPI Stories
share with facebook
share with twitter
Trending Stories